Adeniz - AM – the medicine influencing a cardiovascular system. Valsartan and amlodipin, for treatment of essential hypertensia at adult patients, arterial blood pressure which is not regulated by monotherapy amlodipiny or valsartany.
Structure- 1 tablet contains
: 160 mg of a valsartan and an amlodipin of the besilat that is equivalent to 5 mg of an amlodipin;
- other components: microcrystalline cellulose, sodium of a kroskarmeloz, silicon dioxide colloidal anhydrous, magnesium stearate, polyethyleneglycol 6000 (macrogoal 6000), gipromeloza, titan dioxide (E 171), talc.
Contraindication
- hypersensitivity to active substance, derivatives of dihydropyridine or to any of medicine excipients;
- heavy abnormal liver functions, biliary cirrhosis or cholestasia;
- pregnancy or planning of pregnancy;
- heavy hypotension.
Patients at whom the ABP is inadequately regulated by monomedicaments of an amlodipin or valsartan can be transferred to
to combination therapy by Adeniz-AM medicine. The recommended dose – 1 tablet a day. The pill Adeniz-AM can be taken irrespective of food. Adeniz-AM is recommended to accept, washing down him with a small amount of water. Pregnant
Medicine it is contraindicated to the pregnant women or women who are going to become pregnant to apply
Feature of use
. ChildrenAdeniz-AM is not recommended to apply
to treatment of children. Drivers
patients applying Adeniz-AM can have a dizziness or weakness after intake of medicine therefore they have to consider it at control of motor transport and work with potentially dangerous mechanisms.
Overdose
is absent experience of overdose by Adeniz-AM medicine So far. The main symptom of overdose valsartany presumably is the profound arterial hypotension with dizziness. The overdose of an amlodipin can lead to the accruing peripheral vazodilatation and probably reflex tachycardia. Reported about the considerable and potentially prolonged system hypotension, up to shock and a lethal outcome.
Side effects
Infection and invasion: nasopharyngitis, flu.
from blood and lymphatic system: decrease in level of hemoglobin and hematocrit, leukopenia, neutropenia.
from the immune system: hypersensitivity.
Storage conditionsto Store
at a temperature not above 30 °C in original packing. to Store
out of children's reach.
Characteristics | |
Active ingredients | Amlodipin, Valsartan |
Amount of active ingredient | 160 mg + 5 mg |
Applicant | Microchemical |
Code of automatic telephone exchange | C09DB01 Valzartan and amlodipin |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Market status | The branded generic |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | blister |
Producer | MICROCHEMICAL NPF OF LTD COMPANY |
Quantity in packing | 30 tablets |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Domestic |
Storage temperature | from 5 °C to 25 °C |
Trade name | Adeniz |
Adeniz-AM of the tab. of p/o 160mg/5mg No. 30
- Product Code: 182276
- In Stock
- Ready to ship
-
$23.77